跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Cetirivin
Approved
STANDARD
Cetirivin
Umedica Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b4059a9c3f74e744
Company
Umedica Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
b4059a9c3f74e744
Drug Approval Philippines Name
Cetirivin
Product Name
Cetirivin
Registration Number
DRP-1182-05
Brand Name
Cetirivin
Generic Name
Cetirizine Dihydrochloride
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
Umedica Laboratories Pvt. Ltd.
Importer
Suhitas Pharmaceuticals Inc
Distributor
Pharmaxicare Inc.
Company Detail Path
/organization/umedica-laboratories-pvt-ltda
Issuance Date
21 July 2023
Expiry Date
16 December 2028
Pharmacologic Category
H1-Receptor Antagonist (Antihistamine)
Classification
Over-the-Counter Drug (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b4059a9c3f74e744
Type
Standard
Back to Philippines FDA Approvals
Cetirivin - Philippines FDA Drug Approval Details